Literature DB >> 11208699

Diagnostic guidelines for Kawasaki disease.

.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11208699     DOI： 10.1161/01.cir.103.2.335

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  38 in total

1.  Polymorphism of Fc gamma RIIa may affect the efficacy of gamma-globulin therapy in Kawasaki disease.

Authors:  Shoichiro Taniuchi; Midori Masuda; Masayuki Teraguchi; Yumiko Ikemoto; Yutaka Komiyama; Hakuo Takahashi; Minoru Kino; Yohnosuke Kobayashi
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

2.  Plasma follistatin-like protein 1 is elevated in Kawasaki disease and may predict coronary artery aneurysm formation.

Authors:  Mark Gorelik; David C Wilson; Yona K Cloonan; Stanford T Shulman; Raphael Hirsch
Journal:  J Pediatr       Date:  2012-02-07       Impact factor: 4.406

3.  N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.

Authors:  Hyuksool Kwon; Jin Hee Lee; Jae Yun Jung; Young Ho Kwak; Do Kyun Kim; Jin Hee Jung; Ikwan Chang; Kyuseok Kim
Journal:  Eur J Pediatr       Date:  2016-10-31       Impact factor: 3.183

4.  An atypical case of a 2-year-old boy with acute kidney injury: a race against time. Answers.

Authors:  Werner Keenswijk; Johan Vande Walle
Journal:  Pediatr Nephrol       Date:  2016-10-04       Impact factor: 3.714

5.  Subangular mandibular abscess as presentation of Kawasaki Disease.

Authors:  Tommaso Alterio; Romina Gallizzi; Vincenzo Salpietro; Sabrina Cardile; Roberta Centorrino; Sara Manti; Valeria Chirico; Giorgio Ciprandi; Carmelo Salpietro
Journal:  Indian J Pediatr       Date:  2014-03-14       Impact factor: 1.967

6.  Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines.

Authors:  Sunil J Ghelani; Craig Sable; Bernhard L Wiedermann; Christopher F Spurney
Journal:  Pediatr Cardiol       Date:  2012-02-15       Impact factor: 1.655

7.  Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis.

Authors:  Kee-Soo Ha; GiYoung Jang; JungHwa Lee; KwangChul Lee; YoungSook Hong; ChangSung Son; JooWon Lee
Journal:  Eur J Pediatr       Date:  2012-11-16       Impact factor: 3.183

8.  Peribronchovascular haze: a frequently observed finding on chest X-rays in the acute phase of Kawasaki disease.

Authors:  Shingo Moriya; Jun Aoki; Masahiko Tashiro; Ayako Taketomi-Takahashi; Yoshito Tsushima
Journal:  Jpn J Radiol       Date:  2013-11-29       Impact factor: 2.374

9.  Multisystem inflammatory syndrome (MIS-C) in Pakistani children: A description of the phenotypes and comparison with historical cohorts of children with Kawasaki disease and myocarditis.

Authors:  Shazia S Mohsin; Qalab Abbas; Devyani Chowdhary; Farah Khalid; Abdul Sattar Sheikh; Zuviya Ghazala Ali Khan; Nadeem Aslam; Omaima Anis Bhatti; Maha Inam; Ali Faisal Saleem; Adnan T Bhutta
Journal:  PLoS One       Date:  2021-06-21       Impact factor: 3.240

10.  Immunoglobulin V(H) chain gene analysis of peripheral blood IgM-producing B cells in patients with Kawasaki disease.

Authors:  Hyun Hee Lee; In Ho Park; Jeon-Soo Shin; Jun Soo Shin; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.